The frequency of MBL2 mutations at four positions, MBL2 genotypes and MBL deficiency (defined as serum levels <0.5 μg/mL) was similar in SSc cases and controls, as were overall MBL serum levels (Table 2). This evidence concerns the gene MBL2 and systemic sclerosis.